We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$1.1B
Cap. Flow
+$840M
Cap. Flow %
6.56%
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$16.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$15.2M
3
T icon
AT&T
T
+$14.3M
4
XOM icon
ExxonMobil
XOM
+$14.1M
5
IBM icon
IBM
IBM
+$13.3M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Healthcare 14.47%
3 Technology 14.27%
4 Communication Services 9.94%
5 Consumer Staples 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TM icon
51
Toyota
TM
$234B
$46.5M 0.36%
465,476
+49,826
+12% +$5.12M
ADP icon
52
Automatic Data Processing
ADP
$110B
$46.5M 0.36%
505,647
+21,902
+5% +$1.93M
BAC icon
53
Bank of America
BAC
$416B
$46.3M 0.36%
3,488,320
+531,431
+18% +$7.47M
NVO
54
Novo Nordisk
NVO
$192B
$46.2M 0.36%
1,719,820
+101,522
+6% +$2.78M
MFA
55
MFA Financial
MFA
$855M
$46.1M 0.36%
1,585,481
+243,054
+18% +$6.84M
EG icon
56
Everest Group
EG
$14.6B
$45.8M 0.36%
250,619
+59,414
+31% +$10.9M
PNW icon
57
Pinnacle West Capital
PNW
$11.6B
$45.7M 0.36%
564,329
+7,422
+1% +$553K
GILD icon
58
Gilead Sciences
GILD
$182B
$45.1M 0.35%
540,175
-18,976
-3% -$1.68M
ABBV icon
59
AbbVie
ABBV
$463B
$44.3M 0.35%
715,530
+36,503
+5% +$2.22M
HON icon
60
Honeywell
HON
$63.8B
$43.2M 0.34%
412,999
+37,497
+10% +$3.85M
SLB icon
61
SLB Ltd
SLB
$79.1B
$42M 0.33%
531,662
+85,514
+19% +$6.56M
GOLD
62
DELISTED
Randgold Resources Ltd
GOLD
$42M 0.33%
374,452
+50,470
+16% +$4.68M
MDT icon
63
Medtronic
MDT
$120B
$41.5M 0.32%
478,831
+44,538
+10% +$3.6M
NEE icon
64
NextEra Energy
NEE
$170B
$41.5M 0.32%
1,272,948
+188,344
+17% +$5.65M
AFL icon
65
Aflac
AFL
$58.7B
$41.4M 0.32%
1,147,840
+150,426
+15% +$5.14M
NKE icon
66
Nike
NKE
$55B
$41.4M 0.32%
749,196
-44,355
-6% -$2.53M
C icon
67
Citigroup
C
$228B
$40.6M 0.32%
956,611
+182,780
+24% +$8.08M
TRV icon
68
Travelers Companies
TRV
$78.9B
$40.5M 0.32%
340,294
+45,637
+15% +$5.16M
MA icon
69
Mastercard
MA
$503B
$39.7M 0.31%
450,696
+50,158
+13% +$4.79M
LMT icon
70
Lockheed Martin
LMT
$122B
$39.4M 0.31%
158,697
+6,148
+4% +$1.45M
ACN icon
71
Accenture
ACN
$119B
$39.2M 0.31%
345,739
+14,237
+4% +$1.65M
LLY icon
72
Eli Lilly
LLY
$1.01T
$38.3M 0.3%
485,775
+2,420
+0.5% +$182K
COST icon
73
Costco
COST
$408B
$38.2M 0.3%
243,250
-5,974
-2% -$905K
SBUX icon
74
Starbucks
SBUX
$113B
$38M 0.3%
665,933
+9,612
+1% +$547K
ANAT
75
DELISTED
American National Group, Inc. Common Stock
ANAT
$36.9M 0.29%
325,718
+25,126
+8% +$2.92M

Similar funds

Aperio Group's Q2 2016 Portfolio in Review

As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.

  • Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
  • Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
  • Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
  • Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
  • Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
  • Aperio Group opened 79 new positions and closed 98 in Q2 2016.
  • Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.

Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.